SCHEMBL6784909

SCHEMBL6784909

Cc1cc(C)c2[nH]c3cnn(C)c3c(=O)c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.51
HSD17B10 Q99714 2/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39
GRIN2C Q14957 1/20 0.39
GRIN3A Q8TCU5 1/20 0.39
MAPT P10636 1/20 0.37
PARP1 P09874 2/20 0.35
DAO P14920 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
HRH4 Q9H3N8 1/20 0.34
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA9 Q16790 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6785080 0.86 ABCB1 (0.37) ABCB1HSD17B10ADORA3ADORA2AADORA1
SCHEMBL6791986 0.86 ABCB1 (0.37) ABCB1HSD17B10GRIN2DGRIN3BGRIN1
SCHEMBL6781520 0.78 MEN1 (0.53) HSD17B10MAPTCYP1A2CYP2C19CA12
SCHEMBL6792539 0.78 GRIN2D (0.36) HSD17B10GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6787155 0.73 DAO (0.38) HSD17B10DAOKDM4EALDH1A1GLA
SCHEMBL6785897 0.73 DAO (0.35) HSD17B10DAOKDM4EALDH1A1GLA
SCHEMBL13995640 0.73 ABCB1 (0.70) ABCB1HSD17B10GRIN2DGRIN3BGRIN1
SCHEMBL6787376 0.72 DAO (0.38) HSD17B10DAOHRH4ADORA3ADORA2A
SCHEMBL6786716 0.71 AURKA (0.32)
SCHEMBL6787118 0.71 MPO (0.38) HSD17B10DAOKDM4EALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG ABCB1 2754/4885HSD17B10 3513/4885GRIN2D 195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.